Latest Cleveland Clinic Stories
CLEVELAND, Oct. 6, 2011 /PRNewswire/ -- From wearable bionic devices to a concussion management system for athletes, Cleveland Clinic's Top 10 Medical Innovations for 2012 showcase new techniques, therapies and approaches to treating a host of medical conditions. The list of breakthrough devices and therapies was selected by a panel of Cleveland Clinic physicians and scientists and unveiled during Cleveland Clinic's 2011 Medical Innovation Summit. The Top 10 Medical Innovations for 2012...
For the first time, researchers have discovered cardiac rehabilitation can train the heart to quickly return to its normal rate after exercise. In a study reported in Circulation: Journal of the American Heart Association, researchers said heart disease patients with normal heart rate recovery live longer than those with slow heart rate recovery. A heart that returns to normal rate more quickly works better than one that stays revved up for a while. "There's no medicine that can do...
More than 4,000 patients have received brachytherapy for prostate cancer since 1996 Cleveland, OH (PRWEB) September 26, 2011 Prostate cancer specialists at Cleveland Clinic will mark the 15th anniversary of introducing brachytherapy treatment and also the completion of more than 4,000 cases this September as part of the health care system’s recognition of Prostate Cancer Awareness Month. Prostate brachytherapy is a minimally invasive procedure during which radioactive seeds are...
CLEVELAND, Sept. 22, 2011 /PRNewswire/ -- KeyBank Foundation has pledged $1 million to fund annual scholarships to minority students at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. This is the second $1 million gift that KeyBank Foundation has committed to support the KeyBank Minority Medical Student Fellowships at the Cleveland Clinic Lerner College of Medicine. "Strong doctor/patient relationships are essential to delivering quality healthcare," said...
First US hospital to be featured in popular new digital publication for the medical traveler. Chapel Hill, NC (PRWEB) September 15, 2011 Patients Beyond Borders,® the best-selling consumer reference guide for medical tourism, is pleased to announce the official release of FOCUS ON: Cleveland Clinic, profiling one of the top international healthcare centers in the world. Now available as a digital download, Patients Beyond Borders FOCUS ON: Cleveland Clinic will provide global...
Coating stents with medication may allow targeted delivery Researchers at Cleveland Clinic have discovered that cardiac patients receiving medicated stents – a procedure that occurs often when blood vessels are blocked – have a lower likelihood of suffering heart attacks or developing new blockages in the vessel downstream from the stent. Stents have been used to prevent re-narrowing of coronary arteries after balloon angioplasty and newer designs have included coatings with...
LOUISVILLE, Colo., Sept. 13, 2011 /PRNewswire/ -- Building on a track record of serving the nation's top ranked hospitals, Medivance® Inc. is pleased to announce the 2011 U.S. News & World Report 's Top-10 Ranked Honor Roll Hospitals are all users of its Targeted Temperature Management(TM) product, the Arctic Sun®. The announcement was made by Robert Kline, President & CEO, who stated, "It is often said that you are known by the company you keep, and we are honored to be...
CLEVELAND, Sept. 6, 2011 /PRNewswire/ -- The Ohio Third Frontier Commission has awarded $2.5 million in research grants to advance the Philips Healthcare Global Advanced Imaging Innovation Center, a collaboration among Case Western Reserve University, University Hospitals (UH) Case Medical Center and Philips Healthcare. The research projects are part of $30 million in funding awarded throughout the State of Ohio this week by the Ohio Third Frontier Commission. These latest grants fund two...
CLEVELAND, Aug. 25, 2011 /PRNewswire/ -- What is the state of medical innovation in this new era of health care reform? What novel drugs are being developed to treat heart disease? Is cardiovascular innovation still a good investment opportunity? What do the top CEOs in the industry see as the biggest opportunities? Will IBM's Watson supercomputer be able to diagnose disease as well as practicing physicians? These questions - and many others - will be discussed at Cleveland Clinic's 9th...
CLEVELAND, Aug. 16, 2011 /PRNewswire/ -- SironRX Therapeutics, a biotechnology company developing novel regenerative therapies to accelerate dermal and bone healing, announced today a $3.4 million Series A investment led by North Coast Angel Fund. Additional investors include Cleveland Clinic, JumpStart Inc., Fletcher Spaght Investments, Glengary LLC, Ohio Tech Angel Fund III, Early Stage Partners, X Gen Ltd. and a significant number of individuals. (Logo:...
